The critical issue this mature client faced was a timely product release. While release delays prevented them from reaching organizational and financial goals, the product was on the FDA’s Drug Shortage List, which raised the stakes and increased the urgency for production and release. The client had an idea of where they needed to improve and brought CAI in to help with specific issues. CAI's team of experts captured and analyzed batch data to identify areas where the client’s established process and communication flows prevented them from viewing the entire scope of challenges. Their areas of concern were a part of the overall problem, but they were unable to view the “big picture” to realize the process and organizational issues that needed to be addressed.
Learn how CAI helped the client reduce their batch record backlog, minimize their manufacturing error rate, sustain timely productivity and release levels, meet FDA commitments, and achieve an impressive monthly financial return.
info@wilam.comAn initiative ofBioMelbourne NetworkLevel 6, HWT Tower40 City RoadSouthbank, VIC 3006
Wilam means home in the Woi-wurrung language of the Wurundjeri People of the Kulin Nation, the Traditional Owners of the lands on which we are based.We respectfully acknowledge the Traditional Custodians of the unceded lands and waters of Victoria, the Bunurong, Eastern Maar, Gunaikurnai, Wadawurrung and Wurundjeri Woi-wurrung peoples, on which we live and work. We pay respect to their Elders past and present. We acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector. We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.